Answer
Yes, high blood sugar, diabetes and worsening of pre-existing diabetes have been reported during Risperdal Consta (risperidone prolonged-release injection) treatment; patients should be monitored for high-blood-sugar symptoms, with regular glucose-control monitoring for those with diabetes.
Sources for this answer
- RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 41Document updated
Sources checked